Press Release: FDA’s Latest Threat to Dietary Supplements Defies the Dietary Supplement Health and Education Act

FDA’s Latest Threat to Dietary Supplements Defies the Dietary Supplement Health and Education Act For Immediate Release: U.S. Contact: Gretchen DuBeau, ph 800-230-2762 International Contact: Dr Robert Verkerk, ph +44-1306-646-600 November 25, 2008 FDA’S LATEST THREAT TO DIETARY SUPPLEMENTS DEFIES THE DIETARY SUPPLEMENT HEALTH AND EDUCATION ACT ACCORDING TO TWO LEADING HEALTH FREEDOM GROUPS Today, […]

Read More

The JUPITER Study — Is the News as Encouraging as It Seems?

Every major news wire service was abuzz this past week over Crestor. The study released November 9 involved 18,000 patients, and supplied powerful evidence that statins save lives by driving down blood cholesterol and reducing inflammation in arteries as measured by high blood levels of C-reactive protein. In the study published in the New England Journal […]

Read More

What Effects Will the Pending FDA Regulation Changes Have on Stevia and Other Substances?

The FDA is currently receiving comment about Section 912 of its Amendments Act (FDAAA), which deals with the regulation of foods containing substances that have undergone clinical trials; they have now extended that comment period until November 25. The Section 912 regulations could create a major shift in the divide between foods and drugs.

Read More

Johns Hopkins Clinicians Declare the Current RDA Guidelines Inadequate to Correct Vit D Deficiencies

According to an article in the current issue of Journal of Pediatrics, Johns Hopkins University researchers have termed the current RDA guidelines inadequate to correct the widely prevalent vitamin D deficiency in children suffering from cystic fibrosis. In their attempts to restore normal vitamin D levels, their trials used the recommended 50,000 IU of vitamin […]

Read More